The opinion of two Professionals in the know, - Gleason 9 and Gleason 10 prostate cancer is best treated by multiple modalities; surgery, radiation and hormone therapy used in combination.
The Prostate Health Index (phi) Limits the Need for Additional Biopsies
Shingrix – A new and Better Shingles Vaccine
An article in the New York Times describes a new and more effective vaccine against Shingles, which you should consider getting.
Shingles can be a very painful and debilitating disease which most of us are at risk to get. The FDA has approved this new vaccine; Shingrix and it should be generally available within the next month.
There does seem to be an “ouch” factor involved in receiving the vaccine and it does require two separate injections, but getting Shingles is much worse.
We urge that you speak with your doctor and ask if you should be getting this vaccine. Having Shingles is no fun.
Joel T. Nowak, MA, MSW wrote this Post. Joel is the CEO/Executive Director of Cancer ABCs. He is a Cancer Thriver diagnosed with five primary cancers - Thyroid, Metastatic Prostate, Renal, Melanoma, and the rare cancer Appendiceal cancer.
Will Salvage Prostate Cancer Surgery Provide Any Benefit After Failed Radiation?
Hormone Therapy Negatively Impacts African American Men
Short-Term Data Shows Proton Radiation Therapy Better Than IMRT
Caution - Testosterone Flare During Transition from Degarelix to Leuprolide
A Fatal Flaw in the Clinical Trial Consenting Process
More than a majority of cancer patients do not understand that if they enter into a clinical trial they have no guarantee that they will receive the investigational treatment that they believe their doctor wants them to receive! More transparent clinical trial consenting procedures need to be immediately instituted.
Important Announcement for Medicare Recipients
An Expert Discusses What You Need To Know About The Gleason Grading System
Zytiga And Prednisone Provide Significant Benefits Beyond Survival With Newly Diagnosed Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer
The Importance of Being In Charge of Your Health Care Decision Making
Medicare Issues A “C” Code for Coverage of HIFU Treatment of Prostate Cancer In A Hospital Setting
A Better Diagnostic Marker Then PSA
Bisphosphonate Treatment for Men with Non-Metastatic Prostate Cancer Treated With ADT
The Need for Additional Research to Develop Prognostic Tools
Understanding How The Confusion Around Drug Names Develops
Do You Want To Become A Peer Reviewer for the Department of Defense Prostate Cancer Program?
Cancer ABCs Opposes The Proposed Senate Healthcare Legislation
Two Possible Clinical Trial End Points Predicting Survival and Death
The gold standard of clinical trial end points is survival. Since prostate cancer tends to move relatively slowly it can take many years for a clinical trial to be completed. We need better surrogate endpoints for survival so that trials can be completed more quickly allowing new drugs to flow to us.
